Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Rating of “Hold” from Brokerages

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has received a consensus recommendation of “Hold” from the five brokerages that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $4.00.

Several brokerages recently weighed in on BIOX. Weiss Ratings restated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Monday, December 29th. Wall Street Zen raised Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a research note on Saturday, November 22nd. Canaccord Genuity Group reduced their price target on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a research report on Friday, January 2nd. Finally, Oppenheimer downgraded Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a report on Wednesday, October 22nd.

Institutional Trading of Bioceres Crop Solutions

Hedge funds have recently modified their holdings of the company. Ardsley Advisory Partners LP increased its stake in Bioceres Crop Solutions by 4.7% in the second quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company’s stock valued at $4,441,000 after purchasing an additional 45,000 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Bioceres Crop Solutions by 9.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 823,916 shares of the company’s stock valued at $3,761,000 after buying an additional 71,581 shares during the period. Ballast Asset Management LP increased its position in shares of Bioceres Crop Solutions by 69.9% in the 3rd quarter. Ballast Asset Management LP now owns 745,030 shares of the company’s stock valued at $1,048,000 after buying an additional 306,624 shares in the last quarter. Susquehanna International Group LLP acquired a new stake in Bioceres Crop Solutions during the 3rd quarter worth $315,000. Finally, Tudor Investment Corp ET AL lifted its holdings in Bioceres Crop Solutions by 119.4% during the third quarter. Tudor Investment Corp ET AL now owns 220,500 shares of the company’s stock worth $311,000 after acquiring an additional 120,000 shares in the last quarter. 17.68% of the stock is currently owned by institutional investors and hedge funds.

Bioceres Crop Solutions Stock Performance

Bioceres Crop Solutions stock opened at $1.26 on Friday. The company has a market cap of $79.67 million, a PE ratio of -1.50 and a beta of 0.47. The company has a current ratio of 0.94, a quick ratio of 0.64 and a debt-to-equity ratio of 0.19. Bioceres Crop Solutions has a 1 year low of $1.20 and a 1 year high of $7.44. The company’s 50-day moving average is $1.54 and its two-hundred day moving average is $2.35.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.